Frontlight ResearchEarly access
CompletedNo phase
Impact of Sleep Related Breathing Disorders on Outcomes of Acute Pulmonary Embolism
Key facts
- Who runs it
- Alexandria University
- Where
- Egypt1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Completed
- People taking part
- 40 people enrolled
- Started
- 1 Jan 2025
- Ended
- 1 Jan 2026
- Type of study
- Observational
- Treatments tested
- polysomnography
- Record updated
- 21 January 2026
Who can take part
- Age
- 18 years and older
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 3 criteriaShow less
Who can take part
- Age≥18years; Objectively confirmed acute pulmonary embolism by computed tomography pulmonary angiography (CTPA); Hemodynamically stable or clinically stabilized within 72 hours of admission. .Ability to provide informed consent
Who cannot take part
- .Known central sleep apnea without obstructive features. .Inabilityto undergo sleep study evaluation
- Pregnancy
Where is this trial?
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
This study aimsto compare short-termclinical outcomesand one-year recurrence rates in patients with acute pulmonary embolism with versus without sleep-disordered breathing, recruited from Alexandria MainUniversityHospital.
Treatments tested
- polysomnography
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Short- Term Outcome and One -Year Recurrence in Acute Pulmonary Embolism Patients With and Without Sleep - Disordered Breathing
- Record updated
- 21 January 2026